Literature DB >> 15891417

Comorbidity of migraine.

Ann I Scher1, Marcelo E Bigal, Richard B Lipton.   

Abstract

PURPOSE OF REVIEW: Comorbidity refers to the greater than coincidental association of separate conditions in the same individuals. Historically, a number of conditions have been noted to be comorbid with migraine, notably psychiatric disorders (anxiety, depression, panic disorder), epilepsy, asthma, and some congenital heart defects. Migraine sufferers have increased medical costs overall compared with others of the same sex and age, even after considering the cost of specific migraine treatment. Thus, estimates of the burden of migraine often include the costs of conditions comorbid with it. RECENT
FINDINGS: Conditions may be comorbid through a variety of mechanisms. Comorbidity may be an artifact of diagnostic uncertainty when symptom profiles overlap or when diagnosis is not based on objective markers. Comorbidity may arise due to unidirectional causality, such as migraine resulting in blood pressure changes due to headache-specific treatment. Finally, conditions may be comorbid because of shared genetic or other factors that increase the risk of both conditions. In such cases, understanding these shared risk factors may lead to greater understanding of the fundamental mechanisms of migraine.
SUMMARY: In this article, we will review recent developments related to migraine comorbidity. We will emphasize findings related to the comorbidity of migraine with clinical and sub-clinical vascular brain lesions, congenital heart defects, coronary heart disease, psychiatric illness, and other pain conditions.

Entities:  

Mesh:

Year:  2005        PMID: 15891417     DOI: 10.1097/01.wco.0000169750.52406.a2

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  42 in total

1.  Guest Editorial.

Authors:  M S Chong
Journal:  Br J Pain       Date:  2012-08

Review 2.  Why do migraines often decrease as we age?

Authors:  Frederick G Freitag
Journal:  Curr Pain Headache Rep       Date:  2013-10

Review 3.  Practical considerations for the treatment of elderly patients with migraine.

Authors:  Paola Sarchielli; Maria Luisa Mancini; Paolo Calabresi
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  Comorbidity of Migraine.

Authors:  Şebnem Biçakci
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

5.  Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.

Authors:  Michael M Dowling; Michael J Noetzel; Mark J Rodeghier; Charles T Quinn; Deborah G Hirtz; Rebecca N Ichord; Janet L Kwiatkowski; E Steven Roach; Fenella J Kirkham; James F Casella; Michael R DeBaun
Journal:  J Pediatr       Date:  2014-02-13       Impact factor: 4.406

Review 6.  Migraine-associated risks and comorbidity.

Authors:  H C Diener; M Küper; T Kurth
Journal:  J Neurol       Date:  2008-09-30       Impact factor: 4.849

7.  Population-based study of migraine in Spanish adults: relation to socio-demographic factors, lifestyle and co-morbidity with other conditions.

Authors:  César Fernández-de-Las-Peñas; Valentín Hernández-Barrera; Pilar Carrasco-Garrido; Cristina Alonso-Blanco; Domingo Palacios-Ceña; Silvia Jiménez-Sánchez; Rodrigo Jiménez-García
Journal:  J Headache Pain       Date:  2009-12-10       Impact factor: 7.277

Review 8.  Neurovascular pains: implications of migraine for the oral and maxillofacial surgeon.

Authors:  Donald R Nixdorf; Ana M Velly; Aurelio A Alonso
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2008-05       Impact factor: 2.802

9.  The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine.

Authors:  Sami Küçükşen; Emine Genç; Halim Yılmaz; Ali Sallı; İlknur Albayrak Gezer; Ali Yavuz Karahan; Ender Salbaş; Havva Turaç Cingöz; Ömer Nas; Hatice Uğurlu
Journal:  Clin Rheumatol       Date:  2013-02-27       Impact factor: 2.980

Review 10.  [Current diagnosis and treatment of migraine].

Authors:  H-C Diener; Z Katsarava; V Limmroth
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.